Danaher acquires German quality inspection firm Laetus for undisclosed price

Danaher ($DHR), a U.S.-based health technology company, has acquired Laetus, a Germany-based maker of inline quality inspection and track-and-trace systems, for an undisclosed amount. The deal is expected to bolster Laetus' position in R&D as well as grow its global presence based on Danaher's reputation, the company said in a release. Alex Lever, managing director at Laetus, said the combination will grow what the company has to offer to the packaging value chain. "This acquisition reaffirms the Laetus strategy and accomplishments to date," said Christoph Staub, a Laetus general manager. Release

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.